Overexpression of methyl-CpG-binding protein 2 and autoimmunity: evidence from MECP2 duplication syndrome,lupus,MECP2 transgenic and Mecp2 deficient mice
Restricted accessEditorialFirst published online August, 2013
Overexpression of methyl-CpG-binding protein 2 and autoimmunity: evidence from MECP2 duplication syndrome,lupus,MECP2 transgenic and Mecp2 deficient mice
JeffriesMASawalhaAH. Epigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agents. Int J Clin Rheumtol2011; 6: 423–439.
2.
HughesTSawalhaAH. The role of epigenetic variation in the pathogenesis of systemic lupus erythematosus. Arthritis Res Ther2011; 13: 245–245.
3.
SawalhaAHWebbRHanS. Common variants within MECP2 confer risk of systemic lupus erythematosus. PloS One2008; 3: e1727–e1727. doi: 10.1371/journal.pone.0001727.
4.
WebbRWrenJDJeffriesM. Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus. Arthritis Rheum2009; 60: 1076–1084.
5.
Sawalha AH. Xq28 and lupus: IRAK1 or MECP2? Proc Natl Acad Sci U S A 2009; 106: E62; author reply E3. doi: 10.1073/pnas.0904068106.
6.
KaufmanKMZhaoJKellyJA. Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups. Ann Rheum Dis2013; 72: 437–444.
7.
Koelsch KA, Webb R, Jeffries M, et al. Functional characterization of the MECP2/IRAK1 lupus risk haplotype in human T cells and a human MECP2 transgenic mouse. J Autoimmun 2013; 41: 168–74.
8.
YangTRamockiMBNeulJL. Overexpression of methyl-CpG binding protein 2 impairs TH1 responses. Sci Transl Med2012; 4: 163ra58–163ra58.
9.
ShahbazianMYoungJYuva-PaylorL. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron2002; 35: 243–254.
10.
SinghRSinghSBrilesDETaubDDHollingsheadSKLillardJW Jr. CCL5-independent helper T lymphocyte responses to immuno-dominant pneumococcal surface protein A epitopes. Vaccine2012; 30: 1181–1190.
AppayVRowland-JonesSL. RANTES: a versatile and controversial chemokine. Trends Immunol2001; 22: 83–87.
13.
SawalhaAH. Epigenetics and T-cell immunity. Autoimmunity2008; 41: 245–252.
14.
LiYOhmsSJShannonFMSunCFanJY. IL-2 and GM-CSF are regulated by DNA demethylation during activation of T cells, B cells and macrophages. Biochem Biophys Res Commun2012; 419: 748–753.
15.
KimuraHShiotaK. Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1. J Biol Chem2003; 278: 4806–4812.
16.
DolffSBijlMHuitemaMGLimburgPCKallenbergCGAbdulahadWH. Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus. Clin Immunol2011; 141: 197–204.
NagaiTYanagidaTHirohataS. Anti-ribosomal P protein antibody induces Th1 responses by enhancing the production of IL-12 in activated monocytes. Mod Rheumatol2011; 21: 57–62.
19.
CroweSRMerrillJTVistaES. Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features. Arthritis Rheum2011; 63: 2396–2406.
20.
KaplanMJ. Neutrophils in the pathogenesis and manifestations of SLE. Nat Rev Rheumatol2011; 7: 691–699.
21.
WangNHammarstromL. IgA deficiency: what is new?Curr Opin Allergy Clin Immunol2012; 12: 602–608.
22.
LiuZDavidsonA. Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat Med2012; 18: 871–882.
23.
GordonCMatthewsNSchlesingerBC. Active systemic lupus erythematosus is associated with the recruitment of naive/resting T cells. Br J Rheumatol1996; 35: 226–230.
24.
FritschRDShenXIlleiGG. Abnormal differentiation of memory T cells in systemic lupus erythematosus. Arthritis Rheum2006; 54: 2184–2197.
